dc.contributor.author | Klimek, Ludger | |
dc.contributor.author | Price, David | |
dc.contributor.author | Galffy, G. | |
dc.contributor.author | Emmeluth, M. | |
dc.contributor.author | Koltun, A. | |
dc.contributor.author | Kopietz, F. | |
dc.contributor.author | Nguyen , D.T | |
dc.contributor.author | Van Weissenbruch, R. | |
dc.contributor.author | Pohl, W | |
dc.contributor.author | Kuhl, H. C. | |
dc.contributor.author | Scadding, G. | |
dc.contributor.author | Mullol, J. | |
dc.date.accessioned | 2021-03-23T20:28:01Z | |
dc.date.available | 2021-03-23T20:28:01Z | |
dc.date.issued | 2020-10-01 | |
dc.identifier.citation | Klimek , L , Price , D , Galffy , G , Emmeluth , M , Koltun , A , Kopietz , F , Nguyen , D T , Van Weissenbruch , R , Pohl , W , Kuhl , H C , Scadding , G & Mullol , J 2020 , ' Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study ' , International Archives of Allergy and Immunology , vol. 181 , no. 10 , pp. 754-764 . https://doi.org/10.1159/000508749 | en |
dc.identifier.issn | 1018-2438 | |
dc.identifier.other | PURE: 171213041 | |
dc.identifier.other | PURE UUID: 2981c2b5-1d72-4299-8934-bf866d0be5c7 | |
dc.identifier.other | PubMed: 32829329 | |
dc.identifier.other | Scopus: 85092681822 | |
dc.identifier.other | WOS: 000576042300003 | |
dc.identifier.uri | https://hdl.handle.net/2164/16112 | |
dc.description | Acknowledgements: We would like to thank the subjects who participated in the trial. Funding Sources: This study was supported by MEDA Pharma GmbH & Co. KG (a Mylan Company), Bad Homburg, Germany. Technical, editorial, and medical writing assistance were provided under the direction of the authors by Strategix, an affiliate of The Lynx Group, LLC. This assistance was supported by MEDA Pharma GmbH & Co. KG (a Mylan Company). | en |
dc.format.extent | 11 | |
dc.language.iso | eng | |
dc.relation.ispartof | International Archives of Allergy and Immunology | en |
dc.rights | This is an Open Access article licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense), applicable to the online version of the article only. Usage and distribution for com- mercial purposes requires written permission.https://creativecommons.org/licenses/by-nc/4.0/ | en |
dc.subject | Allergic rhinitis | en |
dc.subject | Allergic rhinitis phenotype | en |
dc.subject | Comorbidities | en |
dc.subject | Immunoglobulin E response | en |
dc.subject | Visual analog scale | en |
dc.subject | R Medicine | en |
dc.subject | Immunology and Allergy | en |
dc.subject | Immunology | en |
dc.subject.lcc | R | en |
dc.title | Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1159/000508749 | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85092681822&partnerID=8YFLogxK | en |
dc.identifier.vol | 181 | en |
dc.identifier.iss | 10 | en |